Enteric protozoa in the developed world: a public health perspective

SM Fletcher, D Stark, J Harkness… - Clinical microbiology …, 2012 - Am Soc Microbiol
Several enteric protozoa cause severe morbidity and mortality in both humans and animals
worldwide. In developed settings, enteric protozoa are often ignored as a cause of diarrheal …

Molecular testing for clinical diagnosis and epidemiological investigations of intestinal parasitic infections

JJ Verweij, CR Stensvold - Clinical microbiology reviews, 2014 - Am Soc Microbiol
Over the past few decades, nucleic acid-based methods have been developed for the
diagnosis of intestinal parasitic infections. Advantages of nucleic acid-based methods are …

Dientamoeba fragilis, the neglected trichomonad of the human bowel

D Stark, J Barratt, D Chan, JT Ellis - Clinical Microbiology Reviews, 2016 - Am Soc Microbiol
Dientamoeba fragilis is a protozoan parasite of the human bowel, commonly reported
throughout the world in association with gastrointestinal symptoms. Despite its initial …

Application of PCR-based methods for diagnosis of intestinal parasitic infections in the clinical laboratory

JJ Verweij - Parasitology, 2014 - cambridge.org
For many years PCR-and other DNA-based methods of pathogen detection have been
available in most clinical microbiology laboratories; however, until recently these tools were …

Dientamoeba fragilis in Denmark: epidemiological experience derived from four years of routine real-time PCR

D Röser, J Simonsen, HV Nielsen… - European journal of …, 2013 - Springer
The intestinal protozoon Dientamoeba fragilis remains a clinical entity of dubious
significance. While several previous studies address questions of epidemiology, only a …

A clinical guideline on Dientamoeba fragilis infections

RSFE Van Gestel, JG Kusters, JF Monkelbaan - Parasitology, 2019 - cambridge.org
Dientamoeba fragilis (D. fragilis) is an intestinal parasite frequently detected in humans with
abdominal pain and diarrhoea, but it is also commonly found in asymptomatic subjects …

Dientamoeba fragilis and chronic abdominal pain in children: a case–control study

MJ de Jong, JJ Korterink, MA Benninga… - Archives of disease in …, 2014 - adc.bmj.com
Background The association between Dientamoeba (D.) fragilis and the aetiology of
functional gastrointestinal disorders (FGID) in children is unclear. Aim The aim of this …

[HTML][HTML] Current treatment options for Dientamoeba fragilis infections

N Nagata, D Marriott, J Harkness, JT Ellis… - International Journal for …, 2012 - Elsevier
Dientamoeba fragilis belongs to the trichomonad group of protozoan parasites and it has
been implicated as a cause of gastrointestinal disease with world-wide prevalences ranging …

Metronidazole therapy for treating dientamoebiasis in children is not associated with better clinical outcomes: a randomized, double-blinded and placebo-controlled …

D Röser, J Simonsen, CR Stensvold… - Clinical infectious …, 2014 - academic.oup.com
Dientamoeba fragilis is a common intestinal protozoan of unresolved clinical significance. In
a double-blinded placebo-controlled trial we show that eradicative metronidazole therapy …

[HTML][HTML] Detection of intestinal protozoa in paediatric patients with gastrointestinal symptoms by multiplex real-time PCR

L Maas, JW Dorigo-Zetsma, CJ De Groot… - Clinical Microbiology …, 2014 - Elsevier
The performance of a multiplex real-time PCR for the detection of Blastocystis, Dientamoeba
fragilis, Giardia lamblia, Cryptosporidium species and Entamoeba species in faecal samples …